E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
about
Cellular Plasticity in Prostate Cancer Bone MetastasisEpithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivop21CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1.Wnt signalling and prostate cancer.Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process.Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases.Is garlic a promising food for benign prostatic hyperplasia and prostate cancer?CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling.T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistanceCo-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin.LRP5 knockdown: effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo.Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
P2860
Q28085013-F4EB0202-99F6-4957-B535-79B413A346F6Q30724105-A82188FA-F81D-44F7-BCE6-104E92A50C9FQ33295288-5B54EA09-42B9-42FF-9277-47AC979EFC70Q34685574-E5450672-65B0-424F-88B9-ADE0CC6DF5D4Q36089054-ACA3A99D-FC33-4CDD-A238-F1B497AE4DDEQ36272854-2723F62F-DD56-4B3F-A2C2-AE6F8AB39722Q36617032-202D5925-1E49-4554-971A-7327C65FED25Q36857803-434E0907-C382-40B7-8E77-8676AC6308DFQ36961796-D175C6F7-7DCE-4D15-AA1A-84D2F1E6EAD4Q37437386-1FD02980-4ADE-49BA-811F-F15363AFA547Q37601733-49F466B5-989A-4553-9F64-BCB97CAA9A3AQ40150065-A6328290-12D8-464E-ADB1-D33EFF870AA2Q41873508-4AE1C3E1-2EA6-459B-A2A4-B3CB59DF5A1EQ45290507-6B0D8CD6-6580-4177-8C8C-277D6E7A8E19Q45306974-4BB1186A-5943-46BF-98F8-9437EC388243
P2860
E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
@en
E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
@nl
type
label
E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
@en
E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
@nl
prefLabel
E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
@en
E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
@nl
P2093
P2860
P1433
P1476
E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
@en
P2093
Hoyland JA
Schembri Wismayer D
P2860
P304
P356
10.1046/J.1464-4096.2001.01712.X
P577
2002-03-01T00:00:00Z